Dr. Reddy’s Laboratories Ltd. ADR (NYSE: RDY) is -16.40% lower on its value in year-to-date trading and has touched a low of $12.50 and a high of $16.89 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RDY stock was last observed hovering at around $13.27 in the last trading session, with the day’s loss setting it -0.07%.
Currently trading at $13.20, the stock is 0.81% and -2.27% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.05 million and changing -0.53% at the moment leaves the stock -11.83% off its SMA200. RDY registered -9.34% loss for a year compared to 6-month loss of -16.99%. The firm has a 50-day simple moving average (SMA 50) of $13.507 and a 200-day simple moving average (SMA200) of $14.97072.
The stock witnessed a 1.93% gain in the last 1 month and extending the period to 3 months gives it a -15.76%, and is -3.72% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.09% over the week and 1.23% over the month.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) has around 27048 employees, a market worth around $11.00B and $3.72B in sales. Current P/E ratio is 17.17 and Fwd P/E is 16.45. Profit margin for the company is 17.25%. Distance from 52-week low is 5.60% and -21.86% from its 52-week high. The company has generated returns on investments over the last 12 months (16.88%).
The EPS is expected to shrink by -1.43% this year.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) Top Institutional Holders
329.0 institutions hold shares in Dr. Reddy’s Laboratories Ltd. ADR (RDY), with institutional investors hold 15.04% of the company’s shares. The shares outstanding are 834.42M, and float is at 833.09M with Short Float at 1.93%. Institutions hold 15.04% of the Float.
The top institutional shareholder in the company is JPMORGAN CHASE & CO with over 0.64 million shares valued at $48.67 million. The investor’s holdings represent 1.9149% of the RDY Shares outstanding. As of 2024-06-30, the second largest holder is ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. with 2.07 million shares valued at $157.65 million to account for 1.2406 of the shares outstanding. The other top investors are ROYAL BANK OF CANADA which holds 2.06 million shares representing 1.2345% and valued at over $156.61 million, while MORGAN STANLEY holds 1.2171 of the shares totaling 2.03 million with a market value of $154.67 million.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) Insider Activity
#####
